Justera Health Statistics
Total Valuation
Justera Health has a market cap or net worth of 902,054. The enterprise value is 983,178.
| Market Cap | 902,054 |
| Enterprise Value | 983,178 |
Important Dates
The next estimated earnings date is Friday, May 1, 2026.
| Earnings Date | May 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 247.92M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +44.83% |
| Owned by Insiders (%) | 10.32% |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.91 |
| PB Ratio | -0.35 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 3.13 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.34 |
| EV / Sales | 0.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.28
| Current Ratio | 0.28 |
| Quick Ratio | 0.25 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -94.73% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 68.32% |
| Weighted Average Cost of Capital (WACC) | 10.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.88 |
| Inventory Turnover | 7.23 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +122.22% in the last 52 weeks. The beta is 1.38, so Justera Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | +122.22% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 20.03 |
| Average Volume (20 Days) | 72,148 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Justera Health had revenue of 987,242 and -2.93 million in losses. Loss per share was -0.02.
| Revenue | 987,242 |
| Gross Profit | 613,187 |
| Operating Income | -1.71M |
| Pretax Income | -2.93M |
| Net Income | -2.93M |
| EBITDA | -1.63M |
| EBIT | -1.71M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 37,304 in cash and 114,785 in debt, with a net cash position of -77,480.
| Cash & Cash Equivalents | 37,304 |
| Total Debt | 114,785 |
| Net Cash | -77,480 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -2.59M |
| Book Value Per Share | -0.01 |
| Working Capital | -2.60M |
Cash Flow
| Operating Cash Flow | 288,197 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 62.11%, with operating and profit margins of -172.93% and -296.58%.
| Gross Margin | 62.11% |
| Operating Margin | -172.93% |
| Pretax Margin | -296.58% |
| Profit Margin | -296.58% |
| EBITDA Margin | -165.52% |
| EBIT Margin | -172.93% |
| FCF Margin | n/a |
Dividends & Yields
Justera Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -39.49% |
| Shareholder Yield | -39.49% |
| Earnings Yield | -324.59% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 24, 2022. It was a reverse split with a ratio of 0.1.
| Last Split Date | Feb 24, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
Justera Health has an Altman Z-Score of -28.05 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -28.05 |
| Piotroski F-Score | 4 |